Company Overview
Cytocell Technologies Limited is a Dissolved Private Limited Company.
Registered Address

418 Cambridge Science Park Milton Road, Cambridge, CB4 0PZ
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameCYTOCELL TECHNOLOGIES LIMITED
Company Number05475998
Registered Office Address418 Cambridge Science Park Milton Road
 CB4 0PZ
Company CategoryPrivate Limited Company
Company StatusDissolved
Country of OriginUnited Kingdom
Incorporation Date09/06/2005
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2020
Accounts Last Made Up Date31/03/2019
Accounts Account CategoryDORMANT
Returns Next Due Date06/07/2017
Returns Last Made Up Date08/06/2016
Previous Company NameChanged Date
CYTOCELL LIMITED28 Jun 2007
Directors & Members
Show Resigned
John Anson - Director
(British, 66 years old, born February 1960)
Appointed 23 February 2018
 Active
Michael Evans - Director
(British, 68 years old, born February 1958)
Appointed 28 February 2014
 Active
Kenji Tsujimoto - Director
(Japanese, 55 years old, born March 1971)
Appointed 18 October 2017
 Active
Gregory Williams - Director
(British, 46 years old, born October 1980)
Appointed 30 January 2019
 Active
Secretaries
Show Resigned
Other Company Directorships
John Anson
CYTOCELL LIMITED
OVARIAN CANCER ACTION.
OXFORD GENE TECHNOLOGY (OPERATIONS) LTD
OXFORD GENE TECHNOLOGY (SOUTHERN) LIMITED
OXFORD GENE TECHNOLOGY EBT LIMITED
OXFORD GENE TECHNOLOGY IP LIMITED
OXFORD GENE TECHNOLOGY LIMITED
Michael Evans
CYTOCELL LIMITED
FLUIDIC ANALYTICS LIMITED
GRANT INSTRUMENTS (CAMBRIDGE) LIMITED
OXFORD GENE TECHNOLOGY (OPERATIONS) LTD
OXFORD GENE TECHNOLOGY (SOUTHERN) LIMITED
OXFORD GENE TECHNOLOGY IP LIMITED
OXFORD GENE TECHNOLOGY LIMITED
OXSYBIO LIMITED
PRECISION MEDICINE CATAPULT LIMITED
TAP BIOSYSTEMS GROUP LIMITED
TOZARO LIMITED
Kenji Tsujimoto
CYTOCELL LIMITED
OXFORD GENE TECHNOLOGY (OPERATIONS) LTD
OXFORD GENE TECHNOLOGY (SOUTHERN) LIMITED
OXFORD GENE TECHNOLOGY EBT LIMITED
OXFORD GENE TECHNOLOGY IP LIMITED
OXFORD GENE TECHNOLOGY LIMITED
Gregory Williams
CYTOCELL LIMITED
OXFORD GENE TECHNOLOGY (OPERATIONS) LTD
OXFORD GENE TECHNOLOGY (SOUTHERN) LIMITED
OXFORD GENE TECHNOLOGY EBT LIMITED
OXFORD GENE TECHNOLOGY IP LIMITED
OXFORD GENE TECHNOLOGY LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Mar-2019 31-Mar-2018 31-Mar-2015
Balance Sheet
Fixed Assets - - -
Current Assets - - -
Creditors Due Within One Year - - -
Working Cap - - -
Total Assets Less Current Liabilities - - -
Long-term Liabilities - - -
Net Assets 2 2 2
Share Capital & Reserves
Share Cap - - 2
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 2 2 2
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2019 31-Mar-2018 31-Mar-2015
Tangible Fixed Assets - - -
Fixed Assets - - -
Stocks Inventory - - -
Debtors - - -
Cash Bank In Hand - - -
Current Assets - - -
Creditors Due Within One Year - - -
Net Current Assets Liabilities - - -
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds - - -
Capital Employed - - -
Total Assets Less Current Liabilities - - -
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2019 31-Mar-2018 31-Mar-2015
Liquidity Ratio 0.0 0.0 0.0
Solvency Ratio - - -
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2019 31-Mar-2018 31-Mar-2015
Assets - - -
Debt - - -
Net Assets/Debt 2 2 2
Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around CB4 0PZ
TAKEDA CAMBRIDGE LIMITED
418 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0PZ
CEREVANCE, LTD
418 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0PZ
Document Filings
Final Gazette dissolved via voluntary strike-off
First Gazette notice for voluntary strike-off
Application to strike the company off the register
Confirmation statement made on 8 June 2020 with no updates
Registered office address changed from Begbroke Science Park Begbroke Hill Woodstock Road Begbroke Oxfordshire OX5 1PF England to 418 Cambridge Science Park Milton Road Cambridge CB4 0PZ on 3 January 2020
Confirmation statement made on 8 June 2019 with no updates
Registered office address changed from 4 Technopark Newmarket Road Cambridge Cambs CB5 8PB to Begbroke Science Park Begbroke Hill Woodstock Road Begbroke Oxfordshire OX5 1PF on 8 May 2019
Appointment of Mr Gregory Alun Williams as a director on 30 January 2019
Termination of appointment of Timothy Richard Hall as a director on 19 October 2018
Confirmation statement made on 8 June 2018 with no updates
Appointment of Dr John George Anson as a director on 23 February 2018
Appointment of Mr Kenji Tsujimoto as a director on 18 October 2017
Current accounting period extended from 30 September 2017 to 31 March 2018
Confirmation statement made on 8 June 2017 with updates
Annual return made up to 8 June 2016 with full list of shareholders
Termination of appointment of Neil Martin Lawrie as a director on 31 May 2016
Annual return made up to 9 June 2015 with full list of shareholders
Annual return made up to 9 June 2014 with full list of shareholders
Termination of appointment of Cytocell Ltd as a director
Termination of appointment of Cytocell Ltd as a director
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free